All 14
Ampersand Biosciences Receives SBIR Grant 2024
Ampersand Biosciences and Trudeau Institute have been awarded a $1,084,824 Phase II Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID).
October 29, 2024/by Geoff SanfordSpecies: Ferret
Focus: Validation of Monoclonal Antibodies to Study Respiratory Infections in the Ferret
Ampersand Biosciences awarded SBIR Grant for Immunologic Analysis of Non-Mammalian and Underrpresented Mammalian Models
Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 20, 2022 until Dece,ber 15, 2024 for immunologic analysis of non-mammalian and underrepresented mammalian models.
September 30, 2024/by Geoff SanfordNAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research
Ampersand Biosciences awarded contract by NIAID for further characterization and validation of monoclonal antibodies to study respiratory
Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 30, 2024 until September 29, 2026 to further characterize and validate monoclonal antibodies to study respiratory.
September 30, 2024/by Geoff SanfordNAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research
Ampersand Biosciences participates in Touch a Truck Funraiser 2024
Ampersand Biosciences participated in the annual Touch a Truck Fundraiser in 2024 in Saranac Lake, NY.
September 17, 2024/by Geoff SanfordAmpersand Biosciences Partners with Bioz
Ampersand Biosciences partners with the world's leading life science-focused AI company Bioz.
July 24, 2024/by Geoff SanfordBlock Symposium Tailoring the Immune Response
Ampersand Biosciences generously supported the Block Symposium-Tailoring the Immune Response at the Immunology2024 annual meeting of the american association of immunologists in Chicago, Illinois.
May 6, 2024/by Geoff SanfordAmpersand biosciences participates in Touch a Truck Funraiser 2023
Ampersand Biosciences participated in the annual Touch a Truck Fundraiser in 2023 in Saranac Lake, NY.
September 17, 2023/by Geoff SanfordFrontier Fact: 4 Biotech Companies
Ampersand Biosciences was written about in the Adirondack Frontier for being locally rooted and thriving as a biotechnology company in Saranac Lake.
June 19, 2023/by Geoff SanfordAmpersand Biosciences Receives SBIR Grant 2022
Ampersand Biosciences has been awarded the SBIR Grant for 2022 for immunologic analysis of non-mammalian and underrepresented mammalian models such as hamster.
July 14, 2022/by Geoff SanfordSpecies: Hamster
Focus: Severe infectious diseases, Influenza, SARS-CoV-2
Ampersand Biosciences awarded a contract by the NIAID for the development of Ferret Reagents for us in the characterization of immune responses to respiratory infections in the ferret model
Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on July 1, 2020 until August 31, 2022 to address an urgent need to develop reagents to better understand and describe the immunologic analyses of respiratory infections in the ferret. Phase 1 will produce commercially available ferret-specific immunoreagents. Phase 2 will develop Luminex kits for quantitative multiplex analyses of innate immune mediators.
July 1, 2020/by Geoff SanfordNAICS: 541714 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: AN12 - Health R&D Services; Health Care Services; Applied Research
Ampersand Biosciences awarded contract for Map Analysis by the CDC
Ampersand Biosciences was awarded a contract by the CDC Office of Acquisition Services (OAS) [HHS - CDC] on May 30, 2018 until November 30, 2018 for map analysis.
May 13, 2018/by Geoff SanfordNAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC: B504 - Special Studies/Analysis - Chemical/Biological
Ampersand Biosciences awarded contract for Analyte Identification Services by ACC
Ampersand Biosciences was awarded a contract by the ACC Aberdeen Proving Ground (APG) [DoD - USA - AMC - ACC] on July 20, 2017 until July 31, 2019 for analyte identification services.
July 20, 2017/by Geoff SanfordNAICS: 541711 - Research And Development In Biotechnology
PSC: AN42 - Health R&D Services; Health Care - Other; Applied Research
Ampersand Biosciences in the News: An innovator success story
Ampersand Biosciences was featured as a news story in the NNY360 about its formation as a biomedical research and development company and it's dedication to performing contract work for medical research businesses.
December 7, 2015/by Geoff SanfordAmpersand Biosciences in the News: Saranac Lake Loses One, Gains One in Biotech
Ampersand Biosciences was featured as a news story in the NCPR about its formation as a new biotech company that will stay in Saranac Lake.
January 23, 2015/by Geoff Sanford